IBDEI19L ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21147,1,3,0)
 ;;=3^Aphasia
 ;;^UTILITY(U,$J,358.3,21147,1,4,0)
 ;;=4^R47.01
 ;;^UTILITY(U,$J,358.3,21147,2)
 ;;=^5019488
 ;;^UTILITY(U,$J,358.3,21148,0)
 ;;=I69.320^^101^1027^2
 ;;^UTILITY(U,$J,358.3,21148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21148,1,3,0)
 ;;=3^Aphasia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,21148,1,4,0)
 ;;=4^I69.320
 ;;^UTILITY(U,$J,358.3,21148,2)
 ;;=^5007491
 ;;^UTILITY(U,$J,358.3,21149,0)
 ;;=I69.120^^101^1027^3
 ;;^UTILITY(U,$J,358.3,21149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21149,1,3,0)
 ;;=3^Aphasia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,21149,1,4,0)
 ;;=4^I69.120
 ;;^UTILITY(U,$J,358.3,21149,2)
 ;;=^5007427
 ;;^UTILITY(U,$J,358.3,21150,0)
 ;;=I69.020^^101^1027^4
 ;;^UTILITY(U,$J,358.3,21150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21150,1,3,0)
 ;;=3^Aphasia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,21150,1,4,0)
 ;;=4^I69.020
 ;;^UTILITY(U,$J,358.3,21150,2)
 ;;=^5007395
 ;;^UTILITY(U,$J,358.3,21151,0)
 ;;=I69.820^^101^1027^5
 ;;^UTILITY(U,$J,358.3,21151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21151,1,3,0)
 ;;=3^Aphasia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,21151,1,4,0)
 ;;=4^I69.820
 ;;^UTILITY(U,$J,358.3,21151,2)
 ;;=^5007522
 ;;^UTILITY(U,$J,358.3,21152,0)
 ;;=I69.220^^101^1027^6
 ;;^UTILITY(U,$J,358.3,21152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21152,1,3,0)
 ;;=3^Aphasia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,21152,1,4,0)
 ;;=4^I69.220
 ;;^UTILITY(U,$J,358.3,21152,2)
 ;;=^5007459
 ;;^UTILITY(U,$J,358.3,21153,0)
 ;;=I69.290^^101^1027^11
 ;;^UTILITY(U,$J,358.3,21153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21153,1,3,0)
 ;;=3^Apraxia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,21153,1,4,0)
 ;;=4^I69.290
 ;;^UTILITY(U,$J,358.3,21153,2)
 ;;=^5007484
 ;;^UTILITY(U,$J,358.3,21154,0)
 ;;=I69.390^^101^1027^7
 ;;^UTILITY(U,$J,358.3,21154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21154,1,3,0)
 ;;=3^Apraxia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,21154,1,4,0)
 ;;=4^I69.390
 ;;^UTILITY(U,$J,358.3,21154,2)
 ;;=^5007515
 ;;^UTILITY(U,$J,358.3,21155,0)
 ;;=I69.190^^101^1027^8
 ;;^UTILITY(U,$J,358.3,21155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21155,1,3,0)
 ;;=3^Apraxia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,21155,1,4,0)
 ;;=4^I69.190
 ;;^UTILITY(U,$J,358.3,21155,2)
 ;;=^5007452
 ;;^UTILITY(U,$J,358.3,21156,0)
 ;;=I69.090^^101^1027^9
 ;;^UTILITY(U,$J,358.3,21156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21156,1,3,0)
 ;;=3^Apraxia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,21156,1,4,0)
 ;;=4^I69.090
 ;;^UTILITY(U,$J,358.3,21156,2)
 ;;=^5007420
 ;;^UTILITY(U,$J,358.3,21157,0)
 ;;=I69.890^^101^1027^10
 ;;^UTILITY(U,$J,358.3,21157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21157,1,3,0)
 ;;=3^Apraxia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,21157,1,4,0)
 ;;=4^I69.890
 ;;^UTILITY(U,$J,358.3,21157,2)
 ;;=^5007546
 ;;^UTILITY(U,$J,358.3,21158,0)
 ;;=I69.393^^101^1027^12
 ;;^UTILITY(U,$J,358.3,21158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21158,1,3,0)
 ;;=3^Ataxia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,21158,1,4,0)
 ;;=4^I69.393
 ;;^UTILITY(U,$J,358.3,21158,2)
 ;;=^5007518
 ;;^UTILITY(U,$J,358.3,21159,0)
 ;;=I69.193^^101^1027^13
 ;;^UTILITY(U,$J,358.3,21159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21159,1,3,0)
 ;;=3^Ataxia following nontraumatic intracerebral hemorrhage
